Keyword: CAR-T


AstraZeneca to Buy Cell Therapy Developer Gracell for Up to $1.2 Billion

03.01.2024 -

AstraZeneca has agreed to acquire Gracell Biotechnologies, a Chinese developer of cell therapies for the treatment of cancer and autoimmune diseases, for up to $1.2...

Plant Construction & Process Technology

New Rules For Pharma

27.09.2017 - Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...